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ABSTRACT 
 
Objective – To find more accurate indices that could affect decisions in 
spasticity treatment by investigating the relationship between 
ultrasonographic, electromyographic, and clinical parameters of the 
gastrocnemius muscle in adults with spastic equinus after stroke. 
Design – Observational study.  
Setting – Two university hospitals 
Participants – Forty-three chronic stroke patients with spastic equinus. 
Interventions – Not applicable. 
Main Outcome Measures – Ultrasonographic features were: spastic 
gastrocnemius muscle echo intensity, muscle thickness, and posterior 
pennation angle of the gastrocnemius medialis and lateralis in both legs. 
Electromyographic evaluation included compound muscle action 
potential recorded from the gastrocnemius medialis and lateralis of both 
legs. Clinical assessment of the spastic gastrocnemius muscle was 
performed with the modified Ashworth scale and by measuring ankle 
passive dorsiflexion range of motion. 
Results – Spastic muscle echo intensity was inversely associated with 
proximal (gastrocnemius medialis and lateralis: P=0.002) and distal 
(gastrocnemius medialis and lateralis: P=0.001) muscle thickness, 
  3 
pennation angle (gastrocnemius medialis: P<0.001; gastrocnemius 
lateralis: P=0.010), compound muscle action potential (gastrocnemius 
medialis: P=0.014; gastrocnemius lateralis: P=0.026), and ankle passive 
dorsiflexion range of motion (gastrocnemius medialis: P=0.038; 
gastrocnemius lateralis: P=0.024). The pennation angle was directly 
associated with the proximal (gastrocnemius medialis and lateralis: 
P<0.001) and distal (gastrocnemius medialis: P=0.001; gastrocnemius 
lateralis: P<0.001) muscle thickness of the spastic gastrocnemius 
muscle. The modified Ashworth scale score was directly associated with 
muscle echo intensity (gastrocnemius medialis: P=0.039; gastrocnemius 
lateralis: P=0.027) and inversely related to the pennation angle 
(gastrocnemius medialis and lateralis: P=0.001), proximal 
(gastrocnemius medialis: P=0.016; gastrocnemius lateralis: P=0.009), 
and distal (gastrocnemius lateralis: P=0.006) muscle thickness of the 
spastic gastrocnemius. 
Conclusions – Increased spastic muscle echo intensity was associated 
with reduced muscle thickness, posterior pennation angle, and compound 
muscle action potential amplitude in the gastrocnemius muscle. Building 
on previous evidence that these instrumental features are related to 
botulinum toxin response, these new findings may usefully inform 
spasticity treatment decisions.  
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INTRODUCTION 
 
Spasticity, a common motor dysfunction arising from upper motor 
neuron lesions,1 affects between 17% and 42.6% of patients with chronic 
stroke, with a substantial impact on the continuum of rehabilitative care 
and recovery.2, 3 According to Lance,4 spasticity refers to a motor 
disorder characterized by a velocity-dependent increase in tonic stretch 
reflex (muscle tone), with exaggerated tendon jerks resulting from 
hyperexcitability of the stretch reflex as one component of upper motor 
neuron syndrome. Patients with spastic paresis are disabled by paresis 
(reduced voluntary recruitment of skeletal motor units), soft tissue 
contracture, and muscle overactivity (reduced ability to relax muscles).5, 
6 Muscle contracture in spastic paresis includes atrophy (loss of muscle 
mass), loss of sarcomeres (shortening), accumulation of intramuscular 
connective tissue, increased fat infiltration, and modifications at the 
myotendinous junction.5 Degenerative alterations of muscle properties 
not only interfere with motor function recovery but also increase the 
degree of spasticity and further aggravate motor impairment.2, 7 
Moreover, progressive changes in the spastic muscle may account for the 
loss of response to botulinum toxin type A therapy,8 which is considered 
a first-line treatment for patients with focal spasticity.9 
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Ultrasonography studies to examine disruptions in the normative 
architecture of spastic muscles have documented changes in 
gastrocnemius muscle thickness, fascicle length, pennation angle, and 
echo intensity in patients with ankle spasticity consequent to chronic 
stroke.10, 11 Such structural modifications are associated with the clinical 
features of spastic equinus, including triceps surae muscle stiffness and 
ankle joint range of motion.10, 11 In addition, spastic gastrocnemius 
muscle echo intensity has been shown to relate to the therapeutic 
response to botulinum toxin type A injection,11 the in vivo efficacy of 
which can be measured by the compound muscle action potential 
(CMAP) amplitude, an electromyographic parameter of muscle fiber 
contraction that quantifies the suppressive action of the botulinum toxin 
on neuromuscular transmission.12, 13 
From this basis, a better understanding of the association between 
instrumental and clinical features of muscle spasticity may usefully 
inform clinicians in the appropriate selection of therapeutic approach and 
improve treatment of spasticity.9 The main aim of this study was to 
investigate the relation between ultrasonographic and electromyographic 
parameters measured at the gastrocnemius muscle in adult patients with 
spastic equinus foot resulting from stroke. The secondary aim was to 
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further examine the association between instrumental and clinical 
features of spasticity in patients with stroke. 
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METHODS 
 
This was a 2-center observational study. The inclusion criteria were as 
follows: age >18 years, spastic equinus foot consequent to first-ever 
unilateral ischemic or hemorrhagic stroke (documented by a 
computerized tomography scan or magnetic resonance imaging; 
subarachnoid hemorrhage excluded), gastrocnemius muscle spasticity 
grade of at least 1 on the Modified Ashworth Scale (MAS),14 at least 6 
months since stroke onset, and no botulinum toxin injection into the 
affected leg muscles or rehabilitation treatment in the 5 months before 
recruitment. Exclusion criteria were as follows: fixed contractures 
involving the affected leg, bony deformities of the lower limbs, previous 
neurolytic or surgical treatment for spasticity of the affected leg, and 
other neurologic or orthopedic conditions affecting the lower limbs 
(bilateral stroke, peripheral neuropathy, peripheral nerve lesion, 
myopathy, severe osteoarthritis, recent muscle lesion, recent bone 
fracture, joint replacement). All participants were outpatients and gave 
their informed consent to participate in the study. The study was carried 
out according to the Declaration of Helsinki and was approved by the 
local ethics committee. 
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Ultrasonographic evaluation 
Patients underwent real-time B-mode ultrasonography performed with a 
linear transducer (scanning frequency of 10MHz)a positioned 
perpendicular to the gastrocnemius surface and placed gently over the 
skin using water-soluble transmission gel to avoid pressure-induced 
alterations of the muscle tissue.11 The following ultrasonographic 
features were evaluated: muscle echo intensity, muscle thickness, and 
posterior pennation angle. Patients remained in the prone position with 
their legs outstretched during the procedure. A board of 2 physicians (1 
at each center) with >5 years experience in skeletal muscle ultrasound 
imaging examined all patients (the same ultrasound machine model was 
used at both centers). The examiners were blind to the 
electromyographic and clinical evaluations. 
Muscle echo intensity was visually evaluated in the transverse view at 
each head of the spastic gastrocnemius muscle (the transducer was 
positioned over the midbelly of the muscle bulk) and graded 
semiquantitatively according to the Heckmatt scale (grade I, normative; 
grade II, increase in muscle echo intensity while bone echo is still 
distinct; grade III, marked increase in muscle echo intensity and reduced 
bone echo; grade IV, very high muscle echo intensity and complete loss 
of bone echo).11, 15, 16 This scale is a validated tool with an intraclass 
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correlation coefficient of 0.915 between raters and an intrarater intraclass 
correlation coefficient of 0.972.17 A single examiner evaluated all the 
images and scored the muscle echo intensity in all patients. 
Muscle thickness (distance from the superficial to deep aponeurosis) was 
measured at the gastrocnemius medialis (GM) and gastrocnemius 
lateralis (GL) of the affected and healthy legs.18 The transducer was 
positioned in the transverse view at 2 sites: near the muscle origin 
(proximal site) and at the midbelly of the muscle bulk (distal site).10, 18 
The posterior pennation angle (angle between the orientation of muscle 
fascicles and superficial aponeurosis) was measured at each head of the 
spastic and healthy gastrocnemius muscle.10 The transducer was 
positioned in the longitudinal view at 5cm from the muscle tendon 
junction.10 
 
Electromyographic evaluation 
The CMAP amplitude was recorded from each head of the spastic and 
healthy gastrocnemius muscle by supramaximal posterior tibial nerve 
stimulation (branches for the GM and GL) at the popliteal fossa of both 
legs by means of an electromyographb and disposable silver/silver 
chloride surface electrodes with belly-tendon montage.12, 13 An infrared 
lamp was used to maintain leg skin temperature >31°C during the 
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recording. Patients remained in the prone position with their legs 
outstretched during the procedure. 
A board of 2 physicians (1 at each center) with >10 years of experience 
in electromyography performed all evaluations (the same 
electromyography machine model was used at both centers). 
The examiners were blind to the ultrasonographic and clinical 
evaluations. 
 
Clinical evaluation 
The following clinical features of the affected leg were evaluated: ankle 
joint passive range of motion (PROM) and gastrocnemius muscle 
spasticity as measured by the MAS. Patients remained in the supine 
position with the knees fully extended during the evaluation. A board of 
2 physicians (1 at each center) with >8 years of experience in the 
evaluation of spasticity performed all evaluations. The examiners were 
blind to the ultrasonographic and electromyographic evaluations. 
Ankle PROM was measured using a handheld goniometer. The 
sensitivity of the measurement was arbitrarily at 5°. The dorsiflexion 
angle was defined as positive and the plantar flexion angle as negative, 
taking 0° as the neutral position of the joint.19 
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The MAS is a 6-point scale for grading the resistance of a relaxed limb 
to rapid passive stretch (0, no increase in muscle tone; 1, slight increase 
in muscle tone at the end of the range of motion; 1+, slight increase in 
muscle tone through less than half of the range of motion; 2, more 
marked increase in muscle tone through most of the range of motion; 3, 
considerable increase in muscle tone; 4, joint is rigid).14 For statistical 
purposes, a score of 1 was considered as 1, and a score of 1+ was 
considered a 2 and so on, until 5.20 
 
Statistical analysis 
Statistical analysis was carried out using SPSS version 21.0.c The 
Wilcoxon signed-rank test was used to compare the instrumental 
parameter values between legs (affected vs. healthy) and muscles (GM 
vs. GL) within the same individual. The Spearman rank correlation test 
was performed to assess the association between instrumental and 
clinical features of the spastic gastrocnemius muscle. After dividing the 
patients into 3 groups according to their Heckmatt scale score, the 
Kruskal-Wallis test was used to verify the difference in the distribution 
of values for muscle thickness, posterior pennation angle, and CMAP 
amplitude between groups (GM and GL were analyzed separately). 
Multiple post hoc comparisons between groups were performed with 
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Mann-Whitney tests for muscle thickness, posterior pennation angle, and 
CMAP amplitude. The alpha level for significance was set at P<0.05. 
The Bonferroni correction was used for multiple comparisons; P<0.016 
was set as the significance threshold.21 
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RESULTS 
 
Between September 2012 and December 2013, 43 persons (28 men and 
15 women; mean age, 61.3 years) with spastic equinus foot resulting 
from stroke (mean time since onset, 5.7 years) were recruited from 
among 101 consecutive outpatients with chronic stroke, 58 who were 
excluded according to the inclusion/exclusion criteria. 
There were significant differences in gastrocnemius muscle thickness, 
posterior pennation angle, and CMAP amplitude in the affected leg 
compared with the healthy leg (table 1).  
Comparison of the spastic GM versus the GL showed a significant 
difference in proximal muscle thickness (1.24±0.35 cm vs. 1.09±0.31cm; 
P=0.004), distal muscle thickness (1.07±0.44 cm vs. 0.91±0.44cm; 
P=0.004), posterior pennation angle (15.77°±6.37° vs. 13.6°±5.17°; 
P=0.004), and CMAP amplitude (6.47±4.24 mV vs. 4.95±2.7 mV; 
P=0.014), but not in muscle echo intensity (2.86±0.77 vs. 2.7±0.71; 
P=0.183).  
The Spearman correlation showed a significant direct association 
between the spastic GM and GL for muscle echo intensity (P=0.014), 
proximal muscle thickness (P<0.001), distal muscle thickness (P<0.001), 
and CMAP amplitude (P<0.001). Spastic gastrocnemius muscle echo 
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intensity was inversely associated with proximal muscle thickness (GM: 
P=0.002; GL: P=0.002), distal muscle thickness (GM: P=0.001; GL: 
P=0.001), posterior pennation angle (GM: P<0.001; GL: P=0.01), 
CMAP amplitude (GM: P=0.014; GL: P=0.026), and ankle PROM (GM: 
P=0.038; GL: P=0.024). Furthermore, the posterior pennation angle was 
directly associated with proximal muscle thickness (GM: P<0.001; GL: 
P<0.001) and distal muscle thickness (GM: P=0.001; GL: P<0.001) of 
the spastic gastrocnemius. In addition, the MAS score was directly 
associated muscle echo intensity (GM: P=0.039; GL: P=0.027) and 
inversely associated with posterior pennation angle (GM: P=0.001; GL: 
P=0.001), proximal muscle thickness (GM: P=0.016; GL: P=0.009), and 
distal muscle thickness (GL: P=0.006) of the spastic gastrocnemius 
(table 2). 
Multiple independent-sample Kruskal-Wallis tests showed an overall 
significant difference between groups (namely, Heckmatt scale grades 
II-IV) in the distribution of proximal muscle thickness (GM: P=0.011, 
χ2=9.111; GL: P=0.005, χ2=10.765), distal muscle thickness (GM: 
P=0.009, χ2=9.424; GL: P=0.003, χ2=11.515), posterior pennation angle 
(GM: P<0.001, χ2=20.172; GL: P=0.005, χ2=10.458), and CMAP 
amplitude (GM: P=0.04, χ2=6.452; GL: P=0.002, χ2=12.575).  
Table 3 reports the results of the post hoc comparisons.  
  
Table 1 – Affected vs. healthy leg comparisons (Wilcoxon signed ranks test). 
Outcome measures Muscle 
Affected leg 
Mean (SD) 
Healthy leg 
Mean (SD) 
P value 
 (Z) 
     
GM 1.24 (0.35) 1.56 (0.30) <0.001* (-5.007) Muscle thickness - proximal site (cm) GL 1.09 (0.31) 1.32 (0.25) <0.001* (-4.627) 
     
GM 1.07 (0.44) 1.40 (0.32) <0.001* (-4.672) Muscle thickness - distal site (cm) GL 0.91 (0.44) 1.09 (0.37) <0.001* (-3.577) 
     
GM 15.77 (6.37) 24.05 (6.07) <0.001* (-5.527) Pennation angle (degrees) GL 13.60 (5.17) 17.72 (6.11) <0.001* (-3.804) 
     
GM 6.47 (4.24) 13.30 (6.31) <0.001* (-5.713) CMAP (mV) GL 4.95 (2.70) 11.24 (5.35) <0.001* (-5.308) 
     
Abbreviations: SD, Standard Deviation; GM, Gastrocnemius medialis; GL, Gastrocnemius lateralis.  
* Significant comparison (P<0.05) 
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DISCUSSION 
 
We found a statistically significantly association between an increase in 
muscle echo intensity and a decrease in CMAP amplitude, muscle 
thickness, and posterior pennation angle of the spastic gastrocnemius 
muscle in this group of chronic patients with spastic equinus resulting 
from stroke. Compared with the healthy leg, the gastrocnemius muscle in 
the affected leg showed degenerative changes, including decreased 
posterior pennation angle, muscle thickness, and CMAP amplitude. 
Clinical symptoms of spasticity have been reported to closely relate to 
such various changes in muscle structure as shortening of muscle 
fascicles, reduction of pennation angle, and increased echo intensity.10, 11, 
22-24 Our findings further confirm these previous observations and are in 
keeping with Gracies’s description of the mechanisms underlying muscle 
contracture, including atrophy, shortening, and accumulation of 
intramuscular connective tissue and fat.5, 6 In addition, the patients with 
grade II spastic gastrocnemius muscle echo intensity on the Heckmatt 
scale (i.e., increase in spastic muscle echo intensity while bone echo is 
still distinct) were noted to have a significantly greater CMAP 
amplitude, posterior pennation angle, and muscle thickness than those 
with higher muscle echo intensity (particularly those with Heckmatt 
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scale grade IV, ie, very high muscle echo intensity and complete loss of 
bone echo). To our knowledge, no previous studies to date have 
compared muscle thickness, pennation angle, and CMAP amplitude 
values distributed by echo intensity of the spastic gastrocnemius in 
patients with chronic stroke (see table 2). 
Botulinum toxin acts in the cytosol of nerve endings where it inhibits the 
release of acetylcholine at the neuromuscular junction.23 Progressive 
alteration of the contractile and structural properties of spastic muscles 
may lead to the loss of response to botulinum toxin type A therapy,8 
which is considered a first-line treatment to reduce muscle overactivity 
in adult patients with focal spasticity.9 Our findings show a significant 
association between the instrumental features of the spastic muscle that 
previous studies found to be related to botulinum toxin response (muscle 
echo intensity, CMAP amplitude) and other ultrasonographic parameters 
used to quantify the changes in passive mechanical muscle properties 
(muscle thickness, pennation angle).8, 10-13 In keeping with the 
observational study design, no treatment interventions were performed. 
We may hypothesize, however, that these ultrasonographic and 
electromyographic findings may be useful for making inferences about 
the clinical efficacy of botulinum toxin treatment and about whether it 
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may be less or not useful in patients with higher muscle echo intensity 
and lower muscle thickness, pennation angle, and CMAP amplitude. 
In patients with spasticity, the increased resistance to passive movement 
is related to stretch reflex hyperactivity and nonreflex biomechanical 
changes in muscles.23, 25 In a recent study, Picelli et al.11 evaluated 
changes in gastrocnemius muscle echo intensity in patients with stroke 
and observed a significant association between the MAS and Tardieu 
Scale scores, ankle PROM, and spastic gastrocnemius muscle echo 
intensity in adult patients with spastic equinus foot consequent to 
stroke.11 Here, we clinically evaluated patients by measuring ankle 
PROM according to the MAS. Ankle PROM was reported to correlate 
with changes in the passive mechanical properties of the spastic 
gastrocnemius muscle in patients with stroke.23 The MAS evaluates 
spasticity by grading resistance to rapid passive movement, but it cannot 
differentiate between stretch reflex hyperactivity and nonreflex 
biomechanical changes in spastic muscles.26 Our findings show that 
greater ankle PROM correlates with lower muscle echo intensity and that 
a lower MAS score correlates with a greater pennation angle, greater 
muscle thickness, and lower muscle echo intensity. This is in line with 
previous findings and the hypothesis that the MAS score and ankle 
PROM, because they quantify the changes in the passive properties of 
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muscles, may be correlated with structural alterations in the spastic 
muscle.11 This concept is further confirmed by the significant association 
we found between clinical assessment and ultrasonographic findings. 
 
Study limitations 
This study has several limitations. First, the small sample size may have 
hindered evaluation of a gradient correlation between spastic 
gastrocnemius muscle echo intensity and other instrumental and clinical 
parameters in the post hoc comparisons and correlation analyses. 
Second, we restricted the electromyographic parameters to the CMAP 
amplitude because it is used to quantify the action of the botulinum toxin 
in vivo.12, 13 From a therapeutic point of view, it would have been 
interesting to study its relation with the other instrumental features of 
spastic muscles (eg, echo intensity) associated with the response to 
botulinum toxin type A.11 From a clinical point of view, evaluation of 
other electromyographic parameters (eg, Hoffmann reflex), the tendon, 
and stretch reflexes may have allowed for a more accurate interpretation 
of the present findings.27 Third, the soleus muscle, which has been 
observed to be responsible for spastic equinus foot in 75% of cases,28 
was not evaluated; therefore, our results could be more easily compared 
with those of previous studies in the same field (ultrasonographic 
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evaluation of structural changes in spastic muscles in association with 
clinical features of spastic equinus).10, 11 Fourth, no sonoelastographic 
evaluation of spastic muscles was done. This innovative ultrasound-
based technique is gaining interest from researchers and clinicians as a 
means to evaluate tissue elasticity in comparison with other instrumental 
and clinical parameters in the study of spasticity.29  
To further validate our findings, larger scale studies, including more 
instrumental (electromyographic and ultrasonographic) features of 
spastic muscles, are desirable. A future area of focus would be the 
clinical application of these findings to predict the therapeutic effect of 
botulinum toxin type A therapy in patients with stroke with muscle 
spasticity. 
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CONCLUSIONS 
 
An increase in muscle echo intensity was significantly associated with a 
decrease in CMAP amplitude, muscle thickness, and posterior pennation 
angle of the spastic gastrocnemius muscle in patients with chronic 
stroke. Building on previous studies that used these instrumental features 
to quantify changes in passive mechanical spastic muscle properties, 
which may be responsible for the loss of response to botulinum toxin 
type A,8, 10-13 these new findings may usefully inform treatment decisions 
about how to improve spasticity in patients with chronic stroke. 
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